November 21, 2024: M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms

Question Title

Please provide the email address you used to register for the event:

Question Title

Was this event valuable to you?

Question Title

If you chose "Yes" to the above question why did you rate the event as valuable (choose all that apply):

Question Title

Please rate the following statements about the speaker(s):

  Strongly Disagree Disagree Neutral Agree Strongly Agree
Speaker adequately covered the subject
Speaker was knowledgeable of subject matter
Speaker answered questions clearly
Speaker adequately facilitated the session

Question Title

Please provide any comments to help us improve future events
(topics, virtual attendance suggestions, other suggestions, etc.):

T